Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07502482
Active, not recruiting Observational

The Effect of Magnesium on Post-spinal Headaches

NCT07502482 · tracked via the Priya Life Science Turkey tracker
Sponsor
Haseki Training and Research Hospital
Phase
Observational
Started
2026-04-01
Last updated
2026-07-07

Condition(s) studied

Post-spinal Headache

Investigational drug(s) / intervention(s)

Magnesium

Magnesium: Post-spinal headache in patients receiving magnesium

Study summary

This retrospective cohort study aims to assess the effect of the use of magnesium sulphate in routine clinical practice on the development of post-dural puncture headache in patients undergoing spinal anaesthesia

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * • Patients aged 18-45 * Patients who underwent spinal anaesthesia for elective caesarean section * Patients with an ASA physical status score of I-III * Patients in whom a 25G or 27G pencil-point needle was used for spinal anaesthesia * Patients with complete medical records Exclusion Criteria: * • Patients undergoing emergency surgery * Patients with a history of chronic headaches * Patients who have undergone unsuccessful spinal anaesthesia or multiple attempts * Patients who have undergone combined spinal-epidural anaesthesia * Patients with a contraindication to magnesium sulphate * Patients with insufficient medical records

Primary outcome measure(s)

  • Incidence of post-spinal headache — 1. day
    the number of people who develop a headache following spinal anaesthesia

Trial sites (1)

FacilityCityRegionStatus
Haseki Training and Research Hospital Istanbul Sultangazi

More Haseki Training and Research Hospital trials in Turkey

Oral vs Intravenous Dexamethasone in Total Knee Arthroplasty Recruiting
Recto-intercostal Block for Coronary Artery Bypass Grafting Active, not recruiting
Effects of Dexmedetomidine on Postoperative Neurocognitive Disorder Active, not recruiting
Depression, Illness Perception, and Erectile Dysfunction Outcomes Enrolling by invitation
Evaluation of Fetal Bladder Emptying During the 11-14 Weeks' Ultrasound Examination as a Negative Predictive Marker for Chromosomal Abnormalities Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07502482 on ClinicalTrials.gov ↗ ← All trials in Turkey